1. miR‐922 regulates apoptosis, migration, and invasion by targeting SOCS1 in gastric cancer
   Paerhati Shayimu et al, 2020, The Kaohsiung Journal of Medical Sciences CrossRef
2. Molecular Structure, Binding Affinity, and Biological Activity in the Epigenome
   Balázs Zoltán Zsidó et al, 2020, International Journal of Molecular Sciences CrossRef
3. Novel molecular targets in gastric adenocarcinoma
   Roya Ramezankhani et al, 2021, Pharmacology & Therapeutics CrossRef
4. Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
   Federica Zatterale et al, 2022, Biomolecules CrossRef
5. Selective p300 inhibitor C646 inhibited HPV E6-E7 genes, altered glucose metabolism and induced apoptosis in cervical cancer cells
   Hongpeng He et al, 2017, European Journal of Pharmacology CrossRef
6. Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1
   W.A.S. Ferreira et al, 2021, Brazilian Journal of Medical and Biological Research CrossRef
7. Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines
   Ya-Mei Wang et al, 2017, International Journal of Oncology CrossRef
8. Epigenetic Approaches to Cancer Therapy
   Sabita N. Saldanha et al, 2018, Epigenetics in Human Disease CrossRef
9. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes
   Mohamad Akbari et al, 2020, Inflammopharmacology CrossRef
10. ETV1 inhibition depressed M2 polarization of tumor-associated macrophage and cell process in gastrointestinal stromal tumor via down-regulating PDE3A
    Xueyan Guo et al, 2023, Journal of Clinical Biochemistry and Nutrition CrossRef
11. CBP/p300 inhibitor C646 prevents high glucose exposure induced neuroepithelial cell proliferation
    Baoling Bai et al, 2018, Birth Defects Research CrossRef
12. KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
    Shishan Zhou et al, 2024, Cell Communication and Signaling CrossRef
13. Current development of CBP/p300 inhibitors in the last decade
    Zhang-Xu He et al, 2021, European Journal of Medicinal Chemistry CrossRef
14. The First Whole-Cell Proteome- and Lysine-Acetylome-Based Comparison between Trichophyton rubrum Conidial and Mycelial Stages
    Xingye Xu et al, 2018, Journal of Proteome Research CrossRef
15. Genetic and Epigenetic Targets of Natural Dietary Compounds as Anticancer Agents
    Qiwen Shi et al, 2019, Epigenetics of Cancer Prevention CrossRef
16. Experimental approaches toward histone acetyltransferase modulators as therapeutics
    D. Chen et al, 2021, Medical Epigenetics CrossRef
17. Repurposing Tranexamic Acid as an Anticancer Agent
    Mary E. Law et al, 2022, Frontiers in Pharmacology CrossRef
18. Protein acylation: mechanisms, biological functions and therapeutic targets
    Shuang Shang et al, 2022, Signal Transduction and Targeted Therapy CrossRef
19. Epigenetic biomarkers
    Arnold Bhebhe et al, 2024, Epigenetics in Human Disease CrossRef
20. Effects of the histone acetylase inhibitor C646 on growth and differentiation of adipose-derived stem cells
    Zhimin Wang et al, 2021, Cell Cycle CrossRef